Transposable elements as plasmid-based vectors for long-term gene transfer into tumors

Area of Science:

• Gene Therapy
• Molecular Biology
• Cancer Research

Background:

• Transient gene expression from nonviral vectors limits cancer gene therapy efficacy.
• Sustained therapeutic gene expression is crucial for direct or indirect tumor cell killing.

Purpose of the Study:

• To explore transposon-based systems for enhancing gene expression duration in nonviral cancer gene therapy.
• To provide a protocol for nonviral transposon delivery to experimental tumors.

Main Methods:

• Utilizing transposon elements to achieve genomic integration of plasmid DNA vectors.
• Transfecting tumor and tumor-associated stroma with transposon-based vectors.
• Developing a protocol for gene delivery to solid experimental tumors in mice.

Main Results:

• Transposon-based vectors demonstrate enhanced duration of gene expression compared to traditional nonviral vectors.
• Genomic integration by transposons sustains transgene expression, particularly in rapidly dividing tumor cells.
• The study provides a detailed protocol for successful nonviral transposon-mediated gene delivery.

Conclusions:

• Nonviral transposon-based gene delivery is a promising strategy to overcome transient expression limitations in cancer gene therapy.
• Genomic integration via transposons ensures sustained therapeutic gene expression for improved anti-tumor effects.
• The developed protocol facilitates the application of this technology in preclinical cancer models.